APOTEX INC FDA Approval ANDA 205533

ANDA 205533

APOTEX INC

FDA Drug Application

Application #205533

Documents

Letter2022-08-26

Application Sponsors

ANDA 205533APOTEX INC

Marketing Status

None (Tentative Approval)001

Application Products

001VIAL3.5MG/VIAL0BORTEZOMIBBORTEZOMIB

FDA Submissions

UNKNOWN; ORIG1TA2017-05-12STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

APOTEX INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 205533
            [companyName] => APOTEX INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"BORTEZOMIB","activeIngredients":"BORTEZOMIB","strength":"3.5MG\/VIAL","dosageForm":"VIAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/12\/2017","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-05-12
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.